TABAK, Ö. F. Et Al. 2018. Effectiveness and safety of direct-acting antiviral therapies inchronic hepatitis C infections patients with cirrhosis in Turkey. EASL, THE INTERNATIONAL LIVER CONGRESS 2018 , (Paris, France).

TABAK, Ö. F., ÖZTOPRAK ÇUVALCI, N., KURTARAN, B., ÖNLEN, Y., SARI, N. D., KAYA, S., ... İNCE, N.(2018). Effectiveness and safety of direct-acting antiviral therapies inchronic hepatitis C infections patients with cirrhosis in Turkey . EASL, THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France

TABAK, ÖMER Et Al. "Effectiveness and safety of direct-acting antiviral therapies inchronic hepatitis C infections patients with cirrhosis in Turkey," EASL, THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 2018

TABAK, ÖMER F. Et Al. "Effectiveness and safety of direct-acting antiviral therapies inchronic hepatitis C infections patients with cirrhosis in Turkey." EASL, THE INTERNATIONAL LIVER CONGRESS 2018 , Paris, France, 2018

TABAK, Ö. F. Et Al. (2018) . "Effectiveness and safety of direct-acting antiviral therapies inchronic hepatitis C infections patients with cirrhosis in Turkey." EASL, THE INTERNATIONAL LIVER CONGRESS 2018 , Paris, France.

@conferencepaper{conferencepaper, author={ÖMER FEHMİ TABAK Et Al. }, title={Effectiveness and safety of direct-acting antiviral therapies inchronic hepatitis C infections patients with cirrhosis in Turkey}, congress name={EASL, THE INTERNATIONAL LIVER CONGRESS 2018}, city={Paris}, country={France}, year={2018}}